Bláha M - Search Results

1

Therapeutic erythrocytapheresis in the initial treatment of hereditary hemochromatosis.

Rehácek V, Bláha M, Jirousová H, Cernohorská J, Papousek P. Rehácek V, et al. Among authors: blaha m. Acta Medica (Hradec Kralove). 2012;55(4):180-5. doi: 10.14712/18059694.2015.43. Acta Medica (Hradec Kralove). 2012. PMID: 23631289 Free article.

2

Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia.

Blaha M, Cermanova M, Blaha V, Jarolim P, Andrys C, Blazek M, Maly J, Smolej L, Zajic J, Masin V, Zimova R, Rehacek V. Blaha M, et al. Among authors: blaha v. Atherosclerosis. 2008 Mar;197(1):264-70. doi: 10.1016/j.atherosclerosis.2007.04.022. Epub 2007 May 30. Atherosclerosis. 2008. PMID: 17540382 Clinical Trial.

3

Safety and tolerability of long lasting LDL-apheresis in familial hyperlipoproteinemia.

Bláha M, Cermanová M, Bláha V, Blazek M, Malý J, Siroký O, Solichová D, Filip S, Rehácek V. Bláha M, et al. Among authors: blaha v. Ther Apher Dial. 2007 Feb;11(1):9-15. doi: 10.1111/j.1744-9987.2007.00450.x. Ther Apher Dial. 2007. PMID: 17309569

4

Extracorporeal LDL-cholesterol elimination in the treatment of severe familial hypercholesterolemia.

Bláha M. Bláha M. Acta Medica (Hradec Kralove). 2003;46(1):3-7. Acta Medica (Hradec Kralove). 2003. PMID: 12747532

5

Prevention of infection transmission during stem cell transplantation.

Bláha M, Mericka P, Stepánová V, Splino M, Malý J, Jebavý L, Zák P, Cermanová M, Filip S, Blazek M, Rehácek V. Bláha M, et al. Folia Microbiol (Praha). 2006;51(6):609-13. doi: 10.1007/BF02931627. Folia Microbiol (Praha). 2006. PMID: 17455799

6

Fifteen years of single center experience with stem cell transplantation for multiple myeloma: a retrospective analysis.

Radocha J, Maisnar V, Zavrelová A, Cermanová M, Lánská M, Kmonícek M, Jebavý L, Bláha M, Malý J, Zák P. Radocha J, et al. Among authors: blaha m. Acta Medica (Hradec Kralove). 2013;56(1):9-13. doi: 10.14712/18059694.2014.31. Acta Medica (Hradec Kralove). 2013. PMID: 23909048 Free article.

7

Extracorporeal Elimination of Circulating Pegylated Liposomal Doxorubicin (PLD) to Enhance the Benefit of Cytostatic Therapy in Platinum-Resistant Ovarian Cancer Patients.

Kubeček O, Bláha M, Diaz-Garcia D, Filip S. Kubeček O, et al. Among authors: blaha m. Acta Medica (Hradec Kralove). 2015;58(1):3-8. doi: 10.14712/18059694.2015.84. Acta Medica (Hradec Kralove). 2015. PMID: 26454800 Free article. Review.

8

WAA apheresis registry in the Czech Republic: two centers experience.

Bláha M, Pták J, Cáp J, Ceeová V, Masín V, Filip S, Blazek M. Bláha M, et al. Transfus Apher Sci. 2009 Aug;41(1):27-31. doi: 10.1016/j.transci.2009.05.005. Epub 2009 Jun 12. Transfus Apher Sci. 2009. PMID: 19524488

9

Optimization of therapeutic procedure during LDL-apheresis - verification of the computerized model in clinical practice.

Masin V, Blaha M, Stransky P, Blaha V, Cermanova M, Maly R, Zajic J. Masin V, et al. Among authors: blaha v, blaha m. Transfus Apher Sci. 2007 Feb;36(1):39-45. doi: 10.1016/j.transci.2006.10.004. Epub 2007 Feb 9. Transfus Apher Sci. 2007. PMID: 17292673

10

Lipoprotein apheresis in the treatment of dyslipidaemia - the Czech Republic experience.

Bláha V, Bláha M, Lánská M, Solichová D, Kujovská Krčmová L, Havel E, Vyroubal P, Zadák Z, Žák P, Sobotka L. Bláha V, et al. Among authors: blaha m. Physiol Res. 2017 Apr 5;66(Suppl 1):S91-S100. doi: 10.33549/physiolres.933584. Physiol Res. 2017. PMID: 28379034 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,199 results

Search Page

Filters